Demand For COVID-19 Saliva-Based Detection Kits Experienced Significant Growth, With An Estimated Market Value Of Around US$ 1.6 Bn; States Fact.MR

High Prevalence Of COVID 19, Growing Use Of Point-Of-Care Testing, And Rising Acceptance And Awareness Of Coronavirus Treatment Are Factors Attributed To The Growth Of The Market In The Country.

“Rising awareness of home-based testing of SARS COV-2 infection and adoption of saliva-based detection as a feasible specimen are expected to drive market growth over the decade,” says a Fact.MR analyst.

Fact.MR – A Market Research and Competitive Intelligence Provider: The global COVID-19 saliva-based detection kits market was valued at US$ 1.4 Bn in 2020, with demand expected to decline at a CAGR of -2.8% over the forecast period (2021-2031).

COVID-19 is a severe and infectious disease, with diagnosis at the initial stage playing a significant role in stopping the further increase of cases. At present, the old method of sampling, i.e., nasopharyngeal swab is majorly used for testing. However, the emerging technique of saliva-based testing is a promising alternative for COVID-19 diagnosis.

When patients need to get urgent care for more critical flu-like symptoms, physicians need to perform diagnostic tests as soon as possible. To meet this requirement, test kits should be available at cheaper costs, easy to handle, rapid, and equipment-free. This creates an opportunity for market players to come up with innovative devices to fulfil the requirements of patients and physicians in the future.

For Critical Insights on this Market, Request for More Info at:

https://www.factmr.com/connectus/sample?flag=S&rep_id=6902

Key Takeaways from Market Study

• By product, PCR-based kits hold around 73.5% value share of the global market in 2021.
• Based on technology, RT-qPCR is leading with 49.2% market share in 2021.
• Based on application, COVID-19 diagnosis is leading with 63.1% market share in 2021.
• By end user, diagnostic laboratories dominate the market with a value share of 26.8% in 2021, while on the other hand, academic and research institutes are expected to increase at a higher CAGR of 2.5%.
• By country, the U.S. dominates the North America market with a value share of 91% in 2021.

Due to rising approvals of COVID-19 test kits that are convenient and simple to use, manufacturers are aiming to introduce new products in the market and get them approved.

For Instance, in July 2021, Nalagenetics and Nusantics obtained regulatory approval to launch PCR test kits to detect COVID-19 from saliva samples. These kits will function as alternatives to nasal and throat swab tests.

Leading players are focusing on advancements in in-vitro diagnostic procedures with rapid testing. These advancements are expected to gain popularity and generate high revenue in the market.

For instance, in April 2021, Therma Bright Inc. announced that it had received CE approval from an EU-competent authority of Belgium for its AcuVid™ COVID-19 rapid antigen saliva test.

To Gain In-Depth Insights on COVID-19 Saliva-Based Detection Kits Market, Request Methodology at

https://www.factmr.com/connectus/sample?flag=RC&rep_id=6902

Key Insights Covered in COVID-19 Saliva-based Detection Kits Industry Survey:

• Market Estimates and Forecasts (2020-2031)
• Key Drivers and Restraints Shaping Market Growth
• Segment-wise, Country-wise, and Region-wise Analysis
• Competition Mapping and Benchmarking
• Market Share Analysis By Key Players
• Key Product Innovations and Regulatory Climate
• Recommendation on Key Winning Strategies

Market Developments:

The global market is set to expand due to rise in awareness of early detection of COVID-19 infection. Leading industry players are set to focus on research & development so that they can come up with unique products to strengthen their product portfolios.

In Aug 2020, Lenexa received FDA approval for a saliva-based COVID-19 test.

In April 2021, Qiagen launched artus Prep&Amp as a CE-Marked SARS-CoV-2 test.

Some of the leading players in the market include Thermo Fisher Scientific Inc, Qiagen NV, ACON Laboratories Inc., Assure Tech (Hangzhou) Co. Ltd., Takara Bio Inc., Nantong Diagnose Biotechnology Co., Ltd, KYODO INTERNATIONAL INC., Arcis Biotechnology Limited, GeneProof, Abacus ALS, Hologic Inc, Vitagene, Therma Bright Inc, Zymo Research Corporation, and Salimetrics.

Key Segments Covered in COVID-19 Saliva-based Detection Kits Industry Research

• By Product
  • Rapid Test Kits
  • PCR-based Kits
• By Technology
  • Direct Sample to PCR
  • RT-qPCR
  • Lateral Flow Assays
• By Application
  • COVID-19 Research
  • COVID-19 Diagnostics
• By End User
  • Diagnostic Laboratories
  • Hospitals & Clinics
  • Academic and Research Institutes
  • Biopharma Companies
  • Long Term Care Facilities
  • Home Care Settings
  • Others

For Comprehensive Insights Ask An Analyst Here

https://www.factmr.com/connectus/sample?flag=AE&rep_id=6902

Want More Insights?

Fact.MR brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels that provides an analysis of the latest industry trends in each of the sub-segments from 2020 to 2031.

The global COVID-19 saliva-based detection kits market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights based on product, technology, application, and end user, across seven main regions of the world.

Fact.MR’s Domain Knowledge in Healthcare

Our healthcare consulting team guides organizations at each step of their business strategy by helping you understand how the latest influencers account for operational and strategic transformation in the healthcare sector. Our expertise in recognizing the challenges and trends impacting the global healthcare industry provides indispensable insights and support - encasing a strategic perspective that helps you identify critical issues and devise appropriate solutions.

Explore Fact.MR’s Coverage on the Healthcare Domain

Oligonucleotide Synthesis Market - Oligonucleotide Synthesis Market Analysis by Product (Reagents & Consumables, Equipment, Synthesized Oligonucleotides, DNA Oligonucleotides, RNA Oligonucleotides, Others), by Application (Research, Therapeutics), by End-User (Biotechnology & Pharmaceutical Companies, Research Institutes, Diagnostic Laboratories) & by Region- 2022-2032

Bipolar Disorder Therapeutics Market - Bipolar Disorder Therapeutics Market Analysis, By Drug Class (Antipsychotics Drugs, Anticonvulsants, Mood Stabilizers, Antidepressant Drugs, Anti-anxiety Drugs) - Global Market Insights 2022 to 2026

Sepsis Diagnostics Market - Sepsis Diagnostics Market Analysis by Product (Blood Culture Media, Instruments and Assays & Reagents), Method (Conventional Sepsis Diagnostics, Automated Sepsis Diagnostics, Pathogen, Gram-negative Bacterial Sepsis, Gram-positive Bacterial Sepsis, Fungal Sepsis and Other Pathogens), Technology (Microbiology, Molecular Diagnostics, Immunoassays and Other Technologies) and Region Forecast- 2022-2032

NGS Sample Preparation Market - NGS Sample Preparation Market Analysis by Product Type (NGS Sample Preparation Instruments and NGS Sample Preparation Kits and Reagents & Consumables), Application (NGS Sample Preparation for Drug & Biomarker Discovery, NGS Sample Preparation for Diagnostics, NGS Sample Preparation for Precision Medicines and Others (Agriculture and Animal Research)), End User (Hospitals & Diagnostic Centers, Biotechnology & Pharmaceutical Companies, Academic & Research Institutes and Others (CROs and CMOs) and Region Forecast- 2022-2032

Osteoporosis Therapeutics Market - Osteoporosis Therapeutics Market Analysis, By Drug Class (Bisphosphonates, Selective Estrogen Inhibitor Modulators (SERM), Parathyroid Hormone Therapies, Calcitonin, Rank Ligand Inhibitors), By Route of Administration (Oral, Injectables) - Global Market Insights 2022 to 2026

CNS Therapeutics Market - CNS Therapeutics Market Analysis, By Segment (Pain Management, Anti-psychotics, Anti-depressants, Anti-epilepsy, Anti-Alzheimer’s, Anti-Parkinson’s) - Global Market Insights 2022 to 2026

Newborn Screening Market - Newborn Screening Market by Product (Newborn Screening Instruments, Consumables), by Test Type (Dry Blood Spot Tests, Hearing Tests, Critical Congenital Heart Disease (CCHD) Screening Tests), by Technology (Immunoassays & Enzymatic Screening Tests, Tandem Mass Spectrometry, Molecular Assays, Hearing Screening Technologies, Pulse Oximetry, Others), by End User (Clinical Laboratories, Hospitals) and by Region- 2022 to 2032

Doxorubicin Market - Doxorubicin Market Analysis, By Formulation (Lyophilized Doxorubicin Powder, Doxorubicin Solution), By Cancer Type (Breast Cancer, Prostate Cancer, Ovarian Cancer, Lung Cancer, Bladder Cancer, Stomach Cancer, Leukemia), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, e-Commerce) - Global Market Insights 2022 to 2026

Drug Discovery Services Market - Drug Discovery Services Market Analysis by Process (Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization and Candidate Validation), by Type (Medicinal Chemistry, Biology Services, Drug Metabolism and Pharmacokinetics), by Drug Type (Small Molecules and Biologics) by Therapeutic Area (Oncology, Neurology, Cardiovascular Diseases, Respiratory Diseases, Diabetes and Other Therapeutic Areas) and Region Forecast- 2022-2032

Lab Automation Market - Lab Automation Market by Product (Equipment, Microplate Readers, Software & Informatics, Automated ELISA Systems, Automated Nucleic Acid Purification Systems), by Application (Drug Discovery, Clinical Diagnostics, Genomics Solutions, Proteomics Solutions), by End User (Biotechnology & Pharmaceutical Industries, Research & Academic Institutes, Hospitals & Diagnostic Centers, Forensic Laboratories, Environmental Testing Labs, Food & Beverage Industry) & Region - Forecast to 2021-2031

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

Mahendra Singh

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

Email: sales@factmr.com

Tel: +1 (628) 251-158